The most commonly used experimental animal models are transgenic mice that express human genes associated with familial AD (FAD) that result in the formation of amyloid plaques (by expression of human APP alone or in combination with human PSEN1), whereas human familial AD accounts for only 5% of cases [115,116,117,118,119]. This evidence concerns the gene APP and familial Alzheimer disease.